Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Colombo
Red Hat Certified System Administrator (RHCSA) - RHEL 10
Sanjeewani95
Updated:
Friday at 7:43 PM
NURSING , CAREGIVER , HOTEL & BEAUTY COURSES
IVA Para Medical Campus
Updated:
Thursday at 9:24 AM
Handmade Character Soft Toys Peppa Pig Family
anil1961
Updated:
Wednesday at 9:58 PM
Ad icon
Video Content Creator
pramukag
Updated:
Jun 28, 2026
Ad icon
QA Engineer Intern
pramukag
Updated:
Jun 28, 2026
Electronics
Vehicles
Property
Search
Reply to thread
Forums
ElaKiri.com
News and Updates
The Mu variant is highly resistant to neutralization
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 26857063" data-attributes="member: 562115"><p>A team of Japanese researchers have announced that the Mu variant is highly resistant to neutralization by sera from convalescent or vaccinated individuals. The Mu variant is the The B.1.621 variant, first isolated in Colombia in January 2021. The Mu variant has the mutations P681H (first reported in Alpha), E484K and K417N (which can evade antibodies), R346K and Y144T (consequences still unknown and under investigation)</p><p></p><p>The Japanese team says that this variant was more resistant to neutralization by serum-mediated neutralization than <strong>all other variants of interest or concern that have been identified to date.</strong></p><p>The team from Tokyo states - “Since breakthrough infection by newly emerging variants is a major concern during the current COVID-19 pandemic, we believe that our findings are of significant public health interest."</p><p></p><p>They generated and compared different pseudoviruses harboring the spike proteins of B.1.621 or the other variants of concern and interest. Virus neutralization assays revealed that <strong>B.1.621 was 12.4 times more resistant</strong> to sera taken from eight COVID-19 convalescents who were infected between April and September 2020 than the parental virus was.</p><p></p><p>The variant was also <strong>7.6 times more resistant </strong>to sera obtained from ten individuals who had been immunized with Pfizer-BioNTech’s BNT162b2 vaccine compared with the parental virus.</p><p>A direct comparison of all the pseudoviruses revealed that <strong>B.1.621 was more resistant </strong>to serum-mediated neutralization than all of the other currently recognized variants of interest and concern.</p><p></p><p><a href="https://doi.org/10.1101/2021.09.06.459005" target="_blank">https://doi.org/10.1101/2021.09.06.459005</a></p><p></p><p>[ATTACH=full]143129[/ATTACH]</p></blockquote><p></p>
[QUOTE="imhotep, post: 26857063, member: 562115"] A team of Japanese researchers have announced that the Mu variant is highly resistant to neutralization by sera from convalescent or vaccinated individuals. The Mu variant is the The B.1.621 variant, first isolated in Colombia in January 2021. The Mu variant has the mutations P681H (first reported in Alpha), E484K and K417N (which can evade antibodies), R346K and Y144T (consequences still unknown and under investigation) The Japanese team says that this variant was more resistant to neutralization by serum-mediated neutralization than [B]all other variants of interest or concern that have been identified to date.[/B] The team from Tokyo states - “Since breakthrough infection by newly emerging variants is a major concern during the current COVID-19 pandemic, we believe that our findings are of significant public health interest." They generated and compared different pseudoviruses harboring the spike proteins of B.1.621 or the other variants of concern and interest. Virus neutralization assays revealed that [B]B.1.621 was 12.4 times more resistant[/B] to sera taken from eight COVID-19 convalescents who were infected between April and September 2020 than the parental virus was. The variant was also [B]7.6 times more resistant [/B]to sera obtained from ten individuals who had been immunized with Pfizer-BioNTech’s BNT162b2 vaccine compared with the parental virus. A direct comparison of all the pseudoviruses revealed that [B]B.1.621 was more resistant [/B]to serum-mediated neutralization than all of the other currently recognized variants of interest and concern. [URL]https://doi.org/10.1101/2021.09.06.459005[/URL] [ATTACH type="full" alt="Mu_variant.jpg"]143129[/ATTACH] [/QUOTE]
Insert quotes…
Verification
Nawa warak dahaya keeyada? (Namaya wadi kireema dahaya)
Post reply
Top
Bottom